Objective: To explore the endoscopic detection rate and composition ratio of acid-related diseases in health check-up subjects for providing a clinical reference for the guiding of treatment strategy. Methods: From January 2015 to December 2016, a total of 12 293 health check-up subjects aged 30-79 years were enrolled. All the subjects underwent endoscopy as a health check-up program, and the subjects were divided into 5 age groups. Reflux esophagitis (RE) and peptic ulcer (PU) were confirmed by gastroscopy. Results: The detection rates of RE and PU were 8.8% (1 087 cases) and 8.0% (981 cases), respectively. For male subjects, the detection rates of RE and PU were 13.1% and 11.5%, respectively; in female subjects, the corresponding rates were 4.9% and 4.7%, respectively. The detection rates of RE and PU in male subjects were 9.2% and 10.5% in 30-39 age group, 12.4% and 10.7% in 40-49 age group, 12.9% and 11.4% in 50-59 age group, 15.0% and 13.5% in 60-69 age group, and 15.9% and 9.3% in 70-79 age group, respectively, while the corresponding detection rates in female subjects were 2.6% and 3.6%, 3.3% and 4.6%, 4.3% and 4.3%, 6.4% and 5.2%, and 9.6% and 6.1%, respectively. In male subjects, the detection rate of RE was significantly higher in the 40-49 age group than that in the 30-39 age group (12.4% vs. 9.2%, P<0.05), and was close to that in 50-59 age group (12.4% vs. 12.9%, P>0.05). Conclusions: The endoscopic detection rate of RE is higher than that of PU in the health check-up subjects. Male patients are the key population for prevention and treatment of acid-related diseases, especially in 40-49 age group.
TANG Chenyue, XU Chenying, YU Lifen
. Analysis of endoscopic characteristics of acid-related diseases in 12 293 health check-up subjects in Shanghai[J]. Journal of Diagnostics Concepts & Practice, 2018
, 17(01)
: 51
-55
.
DOI: 10.16150/j.1671-2870.2018.01.009
[1] El-Serag HB, Sweet S, Winchester CC, et al.Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut,2014,63(6):871-880.
[2] He J, Ma X, Zhao Y, et al.A population-based survey of the epidemiology of symptom-defined gastroesophageal reflux disease: the Systematic Investigation of Gastrointestinal Diseases in China[J]. BMC Gastroenterol,2010, 10:94.
[3] Tan VP, Wong BC, Wong WM, et al.Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population[J]. J Clin Gastroenterol,2016,50(1):e1-e7.
[4] Savarino E, de Bortoli N, De Cassan C, et al. The natural history of gastro-esophageal reflux disease: a comprehensive review[J]. Dis Esophagus,2017,30(2):1-9.
[5] Zou D, He J, Ma X, et al.Epidemiology of symptom-defined gastroesophageal reflux disease and reflux esophagitis: the systematic investigation of gastrointestinal disea-ses in China(SILC)[J]. Scand J Gastroenterol,2011,46(2):133-141.
[6] 张慧, 薛艳, 周丽雅, 等. 北京某三级甲等医院35年间主要上消化道疾病及幽门螺杆菌感染的演变[J]. 中华内科杂志,2016,55(6):440-444.
[7] Lee H, Lim Y, Chi S, et al.Relationship between obesity and development of erosive reflux disease: A mediation analysis of the role of cardiometabolic risk factors[J]. Sci Rep,2017,7(1):6375.
[8] Lee SW, Lien HC, Chang CS, et al.Association of metabolic syndrome with erosive esophagitis and Barrett's esophagus in a Chinese population[J]. J Chin Med Assoc,2017,80(1):15-18.
[9] 中华消化杂志编委会. 消化性溃疡诊断与治疗规范 (2016年, 西安)[J]. 中华消化杂志,2016,36(8):508-513.
[10] Freedberg DE, Kim LS, Yang YX.The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association[J]. Gastroenterology,2017, 152(4):706-715.
[11] 李兆申, 徐晓蓉, 许国铭, 等. 反流性食管炎的临床特征分析[J]. 中华消化内镜杂志,2005,22(5):315-318.
[12] 国家消化系统疾病临床医学研究中心, 中华医学会消化内镜学分会, 中国医师协会消化医师分会. 中国巴雷特食管及其早期腺癌筛查与诊治共识(2017,万宁)[J]. 中华内科杂志,2017,56(9):701-711.
[13] Labenz J, Nocon M, Lind T, et al.Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease[J]. Am J Gastroenterol,2006,101(11):2457-2462.
[14] Malfertheiner P, Nocon M, Vieth M, et al.Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study[J]. Aliment Pharmacol Ther,2012,35(1):154-164.
